MELISSA HERNANDEZ: Open Payments
NPI 1407293483 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 45 payments from 14 companies in 2025. Trend: 2023 $896 · 2024 $372 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $199 |
| Lilly USA, LLC | 12 | $132 |
| Sumitomo Pharma America, Inc. | 5 | $112 |
| PFIZER INC. | 4 | $64 |
| ABBVIE INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Theratechnologies Inc. | 1 | $23 |
Products named: EVENITY, GEMTESA, MOUNJARO, ELIQUIS, QULIPTA, JARDIANCE, NURTEC ODT, OTEZLA.
Industry payments across NE — which companies pay providers there.
